Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR
Crossref DOI link: https://doi.org/10.1007/s11239-015-1215-5
Published Online: 2015-04-24
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yasmeen, Faiza
Ghafoor, Muhammad Bilal
Khalid, Abdul Wadood
Latif, Waqas
Mohsin, Shahida
Khaliq, Shagufta
Text and Data Mining valid from 2015-04-24